Form 4: STERIS Executive Reports Routine Stock Vesting and Corrects Prior Ownership Filings

A recent SEC Form 4 filing by STERIS plc's SVP & GM, AST, Kenneth E. Kohler, details the vesting of restricted stock, shares withheld for tax obligations, and a correction to previously reported beneficial ownership figures.

Summary

• Kenneth E. Kohler, SVP & GM, AST at STERIS plc (STE), reported transactions on June 2, 2025, related to the vesting of restricted ordinary shares.
• A total of 219 ordinary shares were withheld by the Issuer to cover tax liabilities from the vesting of 729 restricted shares (373, 131, and 225 shares respectively) at a price of $242.08 per share.
• The 373 restricted shares vested on June 2, 2025, were originally awarded on May 31, 2023.
• The 131 restricted shares vested on June 2, 2025, were originally awarded on June 2, 2021.
• The 225 restricted shares vested on June 2, 2025, were originally awarded on June 2, 2022.
• Following these transactions, Mr. Kohler's direct beneficial ownership of ordinary shares is 5,040.
• The filing explicitly states that shares beneficially owned were erroneously reported in prior Form 4s and are being corrected in this filing to reflect the current amount.
• As of June 3, 2025, 2,137 of Mr. Kohler's ordinary shares remain restricted, with future vesting dates scheduled through June 4, 2027.

Sentiment

Score: 6

Explanation: The document is largely neutral, detailing routine insider transactions (stock vesting and tax withholdings). The positive aspect is the correction of prior reporting errors, which enhances transparency, slightly elevating the sentiment from purely neutral.

Positives

• The vesting of restricted shares represents a positive compensation event for the executive, Kenneth E. Kohler.
• The correction of previously erroneous beneficial ownership figures enhances transparency and accuracy in SEC filings.

Negatives

• The admission that prior Form 4s contained erroneously reported beneficial ownership figures indicates a past reporting inaccuracy, though it has now been corrected.

Risks

• While corrected, the prior erroneous reporting of beneficial ownership could suggest a minor risk of internal data management or reporting oversight, though the current filing addresses this.

Future Outlook

The document provides a clear schedule for the future vesting of 2,137 restricted ordinary shares held by Mr. Kohler, with restrictions lapsing on various dates through June 4, 2027.

Management Comments

• The filing was signed by John P. Ubbing, Authorized Representative under Power of Attorney for Kenneth E. Kohler.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions and does not provide broader industry context or trends. It reflects standard executive compensation practices involving restricted stock units and tax withholdings upon vesting.

Comparison to Industry Standards

• The practice of granting restricted stock units (RSUs) to executives as part of their compensation package is a common industry standard across various sectors, including healthcare and life sciences where STERIS operates.
• The withholding of shares to cover tax obligations upon RSU vesting is also a standard and widely accepted practice, ensuring compliance with employment and tax laws.
• The correction of previously reported beneficial ownership figures, while indicating a past error, aligns with regulatory expectations for transparency and accuracy in SEC filings, demonstrating adherence to disclosure standards.

Stakeholder Impact

• Shareholders: Benefit from increased transparency due to the correction of previously erroneous beneficial ownership figures.
• Employees (specifically Kenneth E. Kohler): Directly impacted by the vesting of restricted stock and the associated tax withholdings, representing a realization of compensation.

Next Steps

• Lapse of restrictions on 513 ordinary shares on June 4, 2025.
• Lapse of restrictions on 373 ordinary shares on May 31, 2026.
• Lapse of restrictions on 225 ordinary shares on June 2, 2026.
• Lapse of restrictions on 513 ordinary shares on June 4, 2026.
• Lapse of restrictions on 513 ordinary shares on June 4, 2027.

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Stock Vesting, Tax Withholding, Beneficial Ownership, SEC Filing